Policy | May 10, 2021
DCGI approves anti-COVID drug developed by DRDO
The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production
The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production
Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong
GSKP announced sale of its newly constructed manufacturing plant at Vemgal, Karnataka to Hetero Labs for a cash consideration of Rs1.8bn
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
Bharat Biotech expects to share further details of the trial results as additional data become available.
Subscribe To Our Newsletter & Stay Updated
